The efflux transport of choline through blood-brain barrier is inhibited by Alzheimer's disease therapeutics

Biomolecules and Therapeutics

Volumn 16, Issue 3, 2008, Pages 179-183

  Lee, Na Young ^a   Kang, Young Sook ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Alzheimer's disease therapeutics; Blood brain barrier; Choline transport; In vivo brain efflux index method; TR BBB cells

Indexed keywords

CHOLINE; DONEPEZIL; N TERT BUTYL ALPHA PHENYLNITRONE; TACRINE; TRITIUM;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CIRCULATION; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; MALE; NONHUMAN; RAT; TRANSPORT KINETICS;

RATTUS;

EID: 69749102937     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.3.179     Document Type: Article

References (28)

1. Allen, D.D., and Smith, Q.R. (2001) Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J. Neurochem. 76, 1032-1041. (Pubitemid 32167376)
2. Blusztajn, J.K., and Wurtman, R.J. (1983) Choline and cholinergic neurons. Science 221, 614-620.
3. Cohen, B.M., Renshaw, P.F., Stoll, A.L., Wurtman, R.J., Yurgelun-Todd, D., and Babb, S.M. (1995) Decreased brain choline uptake in older adults: an in vivo proton magnetic resonance spectroscopy study. J. Am. Med. Assoc. 274, 902-907.
4. Cornford, E.M., Braun, L.D., and Oldendorf, W.H. (1978) Carrier mediated blood-brain barrier transport of choline and certain analogs. J. Neurochem. 30, 299-308.
5. Cornford, E.M. (1985) The blood-brain barrier, a dynamic regulatory interface. Mol. Physiol. 7, 219-259.
6. Dolezal, V., and Tucek, S. (1992) Investigation of the mechanism of the effect of tacrine (tetrahydroaminoacridine) on the metabolism of acetylcholine and choline in brain cortical prisms. J. Neural. Transm. Park. Dis. Dement. Sect. 4, 303-318.
7. Grason, S.I. (1996) Evaluation of tacrine hydrochloride (Cognex) in two parallel-group studies. Acta. Neurol. Scand. Suppl. 165, 114-122. (Pubitemid 26143174)
8. Hosoya, K.I., Takashima, T., Tetsuka, K., Nagura, T., Ohtsuki, S., Takanaga, H., Ueda, M., Yanai, N., Obinata, M., and Terasaki, T. (2000) mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines, a new in vitro BBB model for drug targeting. J. Drug Target. 8, 357-370. (Pubitemid 32366704)
9. Kakee, A., Terasaki, T., and Sugiyama, Y. (1996) Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. J. Pharmacol. Exp. Ther. 277, 1550-1559. (Pubitemid 27167171)
10. Kang, Y.S., Terasaki, T., Ohnishi, T., and Tsuji, A. (1990) In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier. J. Pharmacobiodyn. 13, 353-360. (Pubitemid 20382643)
11. Kang, Y.S., Lee, K.E., Lee, N.Y., and Terasaki, T. (2005) Donepezil, tacrine and alpha-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB). Arch. Pharm. Res. 28, 443-450.
12. Knapp, M.J., Knopman, D.S., Solomon, P.R., Pendlebury, W.W., Davis, C.S., and Gracon, S.I. (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J. Am. Med. Assoc. 271, 985-991.
13. Knecht, K.T., and Mason, R.P. (1993) In vivo spin trapping of xenobiotic free radical metabolites. Arch. Biochem. Biophys. 303, 185-194. (Pubitemid 23199810)
14. Lee, N.Y., and Kang, Y.S. (2006) In vivo brain-to-blood efflux transport of choline at the blood-brain barrier. J. Appl. Pharmacol. 14, 45-49.
15. MaNally, W.P., Pool, W.F., Sinz, M.W., Dehart, P., Ortwine, D.F., Huang, C.C., Chang, T., and Woolf, T.F. (1996) Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens; Evidence for accumulation of tacrine in brain tissue. Drug Metab. Dispos. 24, 628-633. (Pubitemid 26170713)
16. Matsui, K., Mishima, M., Nagai, Y., Yuzuriha, T., and Yoshimura, T. (1999) Absorption, Distribution, Metabolism, and Excretion of Donepezil (Aricept) after a Single Oral Administration to Rat. Drug Metab. Dispos. 27, 1406-1414.
17. Metting, T.L., Burgio, D.E., Terry, A.V., Beach, J.W., Mccurdy, C.R., and Allen, D.D. (1998) Inhibition of brain choline uptake by isoarecolone and lobeline derivatives: implications for potential vector-mediated brain drug delivery. Neurosci. Let. 258, 25-28.
18. Nitsch, R.M., Blusztajn, J.K., Pittas, A.G., Slack, B.E., Growdon, J.H., and Wurtman, R.J. (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 89, 1671-1675.
19. Ohtsuki, S., and Terasaki T. (2007) Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm. Res. 24, 1745-1758. (Pubitemid 47206624)
20. Pardridge, W.M. (1988) Recent advances in blood-brain barrier transport. Annu. Rev. Pharmacol. Toxicol. 28, 25-39. (Pubitemid 18111023)
21. Rho, J.P., and Lipson, L.G. (1997) Focus on donepezil: A reversible acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Formulary 32, 677-678.
22. Sawada, N., Takanaga, H., Matsuo, H., Naito, M., Tsuruo, T., and Sawada, Y. (1999) Choline uptake by mouse brain capillary endothelial cells in culture. J. Pharm. Pharmacol. 51, 847-852. (Pubitemid 29377958)
23. Smith, Q.R. (1993) Drug delivery to brain and the role of carrier-mediated transport. Adv. Exp. Med. Biol. 331, 83-93. (Pubitemid 23180894)
24. Spector, R. (1989) Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J. Neurochem. 53, 1667-1674. (Pubitemid 19283633)
25. Takada, Y., Vistica, D.T., Greig, N.H., Purdon, D., Rapoport, S.I., and Smith, Q.R. (1992) Rapid high affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Res. 52, 2191-2196.
26. Takanaga, H., Ohtsuki, S., Hosoya, K., and Terasaki, T. (2001) GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier. J. Cereb. Blood Flow Metabol. 21, 1232-1239. (Pubitemid 32947490)
27. Wurtman, R.J. (1992) Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. 15, 117-122.
28. Zhao, Q., Pahlmark, K., Smith, M.L., and Siesjo, B.K. (1994) Delayed treatment with the spin trap α-phenyl-n-tert-butyl nitrone (PBN) reduces infarct size following transient middle cerebral artery occlusion in rats. Acta Physiol. Scand. 152, 349-350. (Pubitemid 24351964)